drugset
drugset / Trial / NCT00579384

A Study of the Effects of JNJ-26489112 on the Photic Induced Paroxysmal Electroencephalogram (EEG) Response in Patients With Photosensitive Epilepsy

NCT00579384 ↗

Phase 2 Completed 12 enrolled Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Non-randomizedSingle-groupSingle-blindTreatment

Summary

The purpose of this study is to check the Effects of JNJ-26489112 on the Photic Induced Paroxysmal electroencephalogram (EEG) Response in Patients with Photosensitive Epilepsy.

Timeline

Start
2007-10
Primary completion
2008-07
Completion
2008-07

Drugs

EvaluationDrugModalityDoseRoute
Subject JNJ26489112 Small molecule 3000 mg Oral

Indications

photosensitive epilepsy